© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
Treatment with Tecentriq plus Avastin or with Keytruda alone delays disease progression and improves survival.
The combination improved both overall survival and patient-reported outcomes.
Tecentriq plus Avastin improved both overall survival and patient-reported outcomes.
These drugs, made from living organisms, are big moneymakers partly because they have little competition. It’s a different story in Europe.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
